Identification of a compound heterozygous inactivating ABCC8 gene mutation responsible for young-onset diabetes with exome sequencing.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 14 06 2019
revised: 28 08 2019
accepted: 29 08 2019
pubmed: 4 9 2019
medline: 24 11 2020
entrez: 4 9 2019
Statut: ppublish

Résumé

Activating mutations in the ABCC8 gene cause diabetes and inactivating mutations usually cause hyperinsulinemic hypoglycemia in infancy. Patients with hypoglycemia in infancy due to a heterozygous inactivating mutation have been reported to occasionally progress to diabetes later in life. We explored the gene responsible for diabetes in two brothers, who were suspected to have diabetes at 15 and 18 years-of-age, respectively, with whole exome sequencing, and identified a compound heterozygous ABCC8 gene mutation (p.Arg168Cys and p.Arg1421Cys). Although their father and mother were heterozygous carriers of the p.Arg168Cys and the p.Arg1421Cys mutation, respectively, neither parent had diabetes. These mutations have been reported to be responsible for hypoglycemia in infancy and function as an inactivating mutation. Our results suggest that the inactivating ABCC8 gene mutation is also important in the etiology of diabetes.

Identifiants

pubmed: 31479591
doi: 10.1111/jdi.13138
pmc: PMC7078087
doi:

Substances chimiques

ABCC8 protein, human 0
Sulfonylurea Receptors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-336

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP17K09842

Informations de copyright

© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11969-73
pubmed: 9342346
J Diabetes Investig. 2011 Jun 5;2(3):158-69
pubmed: 24843477
J Biol Chem. 2016 Oct 14;291(42):21971-21983
pubmed: 27573238
Mod Pathol. 2006 Jan;19(1):122-9
pubmed: 16357843
J Diabetes Investig. 2019 Jul;10(4):947-950
pubmed: 30414308
Eur J Endocrinol. 2013 Mar 15;168(4):557-64
pubmed: 23345197
J Clin Invest. 1997 Aug 15;100(4):802-7
pubmed: 9259578
Diabetes. 2017 Jul;66(7):1901-1913
pubmed: 28442472
Diabetes. 2000 Jan;49(1):114-20
pubmed: 10615958
Diabetologia. 2011 Oct;54(10):2575-83
pubmed: 21674179
Science. 1995 Nov 17;270(5239):1166-70
pubmed: 7502040
Pediatr Dev Pathol. 2007 Jan-Feb;10(1):25-34
pubmed: 17378627
EMBO J. 2003 Aug 1;22(15):3833-43
pubmed: 12881418
Lancet. 2003 Jan 25;361(9354):301-7
pubmed: 12559865
Diabetes. 2013 Nov;62(11):3797-806
pubmed: 23903354
Diabetes. 2008 Jul;57(7):1935-40
pubmed: 18390792
Diabetes. 2012 Oct;61(10):2585-91
pubmed: 22855730
Clin Pediatr Endocrinol. 2017;26(3):127-152
pubmed: 28804205
J Clin Invest. 1998 Oct 1;102(7):1286-91
pubmed: 9769320

Auteurs

Norihiko Matsutani (N)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Hiroto Furuta (H)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Shohei Matsuno (S)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Yoshimasa Oku (Y)

Oku Medical Clinic, Wakayama, Japan.

Shuhei Morita (S)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Shinsuke Uraki (S)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Asako Doi (A)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Machi Furuta (M)

Clinical Laboratory Medicine, Wakayama Medical University, Wakayama, Japan.

Hiroshi Iwakura (H)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Hiroyuki Ariyasu (H)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Masahiro Nishi (M)

Department of Clinical Nutrition and Metabolism, Wakayama Medical University, Wakayama, Japan.

Takashi Akamizu (T)

First Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH